It is therefore likely that TP73 isoform regulation in cancer cells is less stringent than in normal cells, and further studies will be necessary to elucidate TP73 isoform regulation and the clinicopathologic characteristics of ΔTAp73 and TAp73 in squamous cell carcinomas and other tumour types. Here, TP73 is linked to cancer.